Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Karl Götte

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
ORL; Journal for Oto-Rhino-Laryngology and Its Related Specialties|May 27, 2004
Sinonasal malignancy: what's new?Karl Götte, Karl Hörmann
Anticancer Research|May 16, 2009
Lymphatic vessel density in correlation to lymph node metastasis in head and neck squamous cell carcinomaStefanie Frech, Karl Hörmann, Frank Riedel, et al.
Advances in Oto-Rhino-Laryngology|December 21, 2004
Antiangiogenic therapy of head and neck squamous cell carcinoma by vascular endothelial growth factor antisense therapyFrank Riedel, Karl Götte, Karl Hörmann, et al.
Anticancer Research|August 28, 2004
Targeting chemotherapy-induced VEGF up-regulation by VEGF antisense oligonucleotides in HNSCC cell linesFrank Riedel, Karl Götte, Ulrich Goessler, et al.
Oncology Reports|May 5, 2005
Altered expression of cell cycle regulators p21, p27, and p53 in tumors of salivary glands and paranasal sinusesAnnette Affolter, Stefanie Helmbrecht, Sonja Finger, et al.
Oncology Reports|December 5, 2003
Intratumoral genomic heterogeneity in primary head and neck cancer and corresponding metastases detected by dual-FISHKarl Götte, Carsten Schäfer, Frank Riedel, et al.
In Vivo (Athens, Greece)|June 29, 2011
IL-6 antisense-mediated growth inhibition in a head and neck squamous cell carcinoma cell lineGregor Bran, Karl Götte, Katrin Riedel, et al.
International Journal of Oncology|July 31, 2003
Abrogation of VEGF expression in human head and neck squamous cell carcinoma decreases angiogenic activity in vitro and in vivoFrank Riedel, Karl Götte, Mengfeng Li, et al.
International Journal of Oncology|June 14, 2002
EGFR antisense treatment of human HNSCC cell lines down-regulates VEGF expression and endothelial cell migrationFrank Riedel, Karl Götte, Mengfeng Li, et al.
International Journal of Molecular Medicine|January 14, 2004
Expression of IL-18 in patients with head and neck squamous cell carcinomaFrank Riedel, Sylvie Adam, Peter Feick, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
ORL; Journal for Oto-Rhino-Laryngology and Its Related Specialties|May 27, 2004
Sinonasal malignancy: what's new?Karl Götte, Karl Hörmann
Anticancer Research|May 16, 2009
Lymphatic vessel density in correlation to lymph node metastasis in head and neck squamous cell carcinomaStefanie Frech, Karl Hörmann, Frank Riedel, et al.
Advances in Oto-Rhino-Laryngology|December 21, 2004
Antiangiogenic therapy of head and neck squamous cell carcinoma by vascular endothelial growth factor antisense therapyFrank Riedel, Karl Götte, Karl Hörmann, et al.
Anticancer Research|August 28, 2004
Targeting chemotherapy-induced VEGF up-regulation by VEGF antisense oligonucleotides in HNSCC cell linesFrank Riedel, Karl Götte, Ulrich Goessler, et al.
Oncology Reports|May 5, 2005
Altered expression of cell cycle regulators p21, p27, and p53 in tumors of salivary glands and paranasal sinusesAnnette Affolter, Stefanie Helmbrecht, Sonja Finger, et al.
Oncology Reports|December 5, 2003
Intratumoral genomic heterogeneity in primary head and neck cancer and corresponding metastases detected by dual-FISHKarl Götte, Carsten Schäfer, Frank Riedel, et al.
In Vivo (Athens, Greece)|June 29, 2011
IL-6 antisense-mediated growth inhibition in a head and neck squamous cell carcinoma cell lineGregor Bran, Karl Götte, Katrin Riedel, et al.
International Journal of Oncology|July 31, 2003
Abrogation of VEGF expression in human head and neck squamous cell carcinoma decreases angiogenic activity in vitro and in vivoFrank Riedel, Karl Götte, Mengfeng Li, et al.
International Journal of Oncology|June 14, 2002
EGFR antisense treatment of human HNSCC cell lines down-regulates VEGF expression and endothelial cell migrationFrank Riedel, Karl Götte, Mengfeng Li, et al.
International Journal of Molecular Medicine|January 14, 2004
Expression of IL-18 in patients with head and neck squamous cell carcinomaFrank Riedel, Sylvie Adam, Peter Feick, et al.
Pageof 2